• Vectura, Inspira Partner to Develop Inhaled COVID Treatment contractpharma
    May 08, 2021
    ​Vectura Group plc, an inhalation CDMO, and Inspira Pharmaceuticals, a UK-based company focused on developing therapies for respiratory and infectious diseases, entered an agreement to develop an inhaled formulation of Inspira’s lead drug candidate ...
PharmaSources Customer Service